{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:12:06Z","timestamp":1792480326757,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004338","name":"Saint Joseph University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005349","name":"American Association of Colleges of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011472","name":"American Academy of Clinical Psychology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023094","name":"Saint Joseph's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.omtn.2023.102086","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:03:42Z","timestamp":1701799422000},"page":"102086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Therapeutic and diagnostic applications of antisense peptide nucleic acids"],"prefix":"10.1016","volume":"35","author":[{"given":"Victoria","family":"MacLelland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Kravitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-9169","authenticated-orcid":false,"given":"Anisha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.102086_bib1","first-page":"261","article-title":"Development of Antisense and Antigene Oligonucleotide Analogs","volume":"52","author":"Miller","year":"1996"},{"key":"10.1016\/j.omtn.2023.102086_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"4","author":"Chery","year":"2016","journal-title":"Postdoc J."},{"key":"10.1016\/j.omtn.2023.102086_bib3","doi-asserted-by":"crossref","first-page":"e12238","DOI":"10.1002\/eng2.12238","article-title":"Potential applications of peptide nucleic acid in biomedical domain","volume":"2","author":"Singh","year":"2020","journal-title":"Eng. Rep."},{"key":"10.1016\/j.omtn.2023.102086_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.15171\/apb.2018.064","article-title":"Potential of Peptide Nucleic Acids in Future Therapeutic Applications","volume":"8","author":"Montazersaheb","year":"2018","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.omtn.2023.102086_bib5","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/jcm9062004","article-title":"Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development","volume":"9","author":"Dhuri","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.omtn.2023.102086_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1261\/rna.079498.122","article-title":"Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics","volume":"29","author":"Pradeep","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2023.102086_bib7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3762\/bjoc.17.116","article-title":"Chemical approaches to discover the full potential of peptide nucleic acids in biomedical applications","volume":"17","author":"Brodyagin","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.omtn.2023.102086_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics \u2014 challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2023.102086_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-0716-0243-0_12","article-title":"Peptide Nucleic Acids for MicroRNA Targeting","volume":"2105","author":"Gambari","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2023.102086_bib10","doi-asserted-by":"crossref","first-page":"20473","DOI":"10.1073\/pnas.1218887109","article-title":"Capturing microRNA targets using an RNA-induced silencing complex (RISC)-trap approach","volume":"109","author":"Cambronne","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.102086_bib11","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in\u00a0vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.102086_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.02.016","article-title":"Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma","volume":"201","author":"Seo","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2023.102086_bib13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41598-017-00966-3","article-title":"Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer","volume":"7","author":"\u00d6ze\u015f","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.102086_bib14","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1021\/bi401085h","article-title":"Binding Interactions between Long Noncoding RNA HOTAIR and PRC2 Proteins","volume":"52","author":"Wu","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2023.102086_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/molecules25030559","article-title":"Antibacterial Peptide Nucleic Acids\u2014Facts and Perspectives","volume":"25","author":"Wojciechowska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2023.102086_bib16","doi-asserted-by":"crossref","first-page":"40268","DOI":"10.1039\/C9RA07812F","article-title":"Discovery of a novel small molecular peptide that disrupts helix 34 of bacterial ribosomal RNA","volume":"9","author":"Gc","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.omtn.2023.102086_bib17","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1073\/pnas.95.5.2073","article-title":"Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA","volume":"95","author":"Good","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.102086_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2023.102086_bib19","first-page":"414729","article-title":"Mechanisms of cellular uptake of cell-penetrating peptides","volume":"2011","author":"Madani","year":"2011","journal-title":"J.\u00a0Biophys."},{"key":"10.1016\/j.omtn.2023.102086_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1541-7786.MCR-19-0661","article-title":"Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation","volume":"18","author":"Kaplan","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omtn.2023.102086_bib21","first-page":"461","article-title":"Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide","volume":"17","author":"Svoronos","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2023.102086_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"MicroRNA silencing for cancer therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102086_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2008.08.124","article-title":"Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen","volume":"376","author":"Wright","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2023.102086_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/86753","article-title":"Bactericidal antisense effects of peptide-PNA conjugates","volume":"19","author":"Good","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.102086_bib26","doi-asserted-by":"crossref","first-page":"e2202859","DOI":"10.1002\/adhm.202202859","article-title":"Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In\u00a0Vivo Targeting of Hepatocytes","volume":"12","author":"Kumar","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.omtn.2023.102086_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bpj.2021.01.004","article-title":"Vitamin B(12)-peptide nucleic acids use the BtuB receptor to pass through the Escherichia coli outer membrane","volume":"120","author":"Pie\u0144ko","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.omtn.2023.102086_bib28","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/s41598-017-08032-8","article-title":"Vitamin B(12) as a carrier of peptide nucleic acid (PNA) into bacterial cells","volume":"7","author":"R\u00f3wnicki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.102086_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acs.bioconjchem.5b00156","article-title":"Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery","volume":"26","author":"Avitabile","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.omtn.2023.102086_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actbio.2018.04.006","article-title":"Customizing poly(lactic-co-glycolic acid) particles for biomedical applications","volume":"73","author":"Swider","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.omtn.2023.102086_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2016.01.005","article-title":"Nanotechnology for delivery of peptide nucleic acids (PNAs)","volume":"240","author":"Gupta","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtn.2023.102086_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omtn.2017.09.001","article-title":"Anti-tumor Activity of miniPEG-\u03b3-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy","volume":"9","author":"Gupta","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.102086_bib33","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1021\/acs.nanolett.8b02166","article-title":"Inhibiting Methicillin-Resistant Staphylococcus aureus by Tetrahedral DNA Nanostructure-Enabled Antisense Peptide Nucleic Acid Delivery","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2023.102086_bib34","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.2147\/IJN.S403882","article-title":"The Current Progress of Tetrahedral DNA Nanostructure for Antibacterial Application and Bone Tissue Regeneration","volume":"18","author":"Hong","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omtn.2023.102086_bib35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.omtn.2021.07.018","article-title":"Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids","volume":"25","author":"Malik","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.102086_bib36","series-title":"Global antimicrobial resistance and use surveillance system (GLASS) report","author":"TEAM","year":"2022"},{"key":"10.1016\/j.omtn.2023.102086_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2023.102086_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence","volume":"88","author":"Christaki","year":"2020","journal-title":"J.\u00a0Mol. Evol."},{"key":"10.1016\/j.omtn.2023.102086_bib39","first-page":"363","article-title":"Adaptive Antibiotic Resistance: Overview and Perspectives","volume":"06","author":"Salimiyan Rizi","year":"2018","journal-title":"J.\u00a0Infect. Dis. Ther."},{"key":"10.1016\/j.omtn.2023.102086_bib40","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AAC.49.8.3203-3207.2005","article-title":"Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection","volume":"49","author":"Tan","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2023.102086_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biochi.2017.04.001","article-title":"Helix 69 of Escherichia coli 23S ribosomal RNA as a peptide nucleic acid target","volume":"138","author":"Kulik","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.omtn.2023.102086_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12866-015-0599-x","article-title":"Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in\u00a0vitro","volume":"15","author":"Goh","year":"2015","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.omtn.2023.102086_bib43","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","article-title":"Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides","volume":"15","author":"He","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtn.2023.102086_bib44","doi-asserted-by":"crossref","first-page":"e201221","DOI":"10.1128\/spectrum.01262-21","article-title":"Potentiating the Anti-Tuberculosis Efficacy of Peptide Nucleic Acids through Combinations with Permeabilizing Drugs","volume":"10","author":"Cotta","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.omtn.2023.102086_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/ph13120483","article-title":"Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B Virus","volume":"13","author":"Ndeboko","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omtn.2023.102086_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jhep.2004.10.010","article-title":"Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA)","volume":"42","author":"Robaczewska","year":"2005","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2023.102086_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.omtn.2017.09.003","article-title":"Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication","volume":"9","author":"Ndeboko","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.102086_bib48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/14712590903052877","article-title":"Prospects for antisense peptide nucleic acid (PNA) therapies for HIV","volume":"9","author":"Pandey","year":"2009","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2023.102086_bib49","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1093\/nar\/gki743","article-title":"Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides","volume":"33","author":"Tripathi","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.102086_bib50","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1093\/nar\/gkm374","article-title":"Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA","volume":"35","author":"Boutimah-Hamoudi","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.102086_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2023.102086_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0024-3205(02)01647-8","article-title":"Peptide nucleic acids specifically cause antigene effects in\u00a0vivo by systemic injection","volume":"71","author":"McMahon","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2023.102086_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12031-002-0013-7","article-title":"Using peptide nucleic acids as gene-expression modifiers to reduce beta-amyloid levels","volume":"19","author":"McMahon","year":"2002","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.omtn.2023.102086_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/JMN:20:3:261","article-title":"Peptide nucleic acids targeted to the amyloid precursor protein","volume":"20","author":"McMahon","year":"2003","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.omtn.2023.102086_bib55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1469-1809.2009.00546.x","article-title":"A mutation that creates a pseudoexon in SOD1 causes familial ALS","volume":"73","author":"Valdmanis","year":"2009","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.omtn.2023.102086_bib56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1471-4159.2003.02053.x","article-title":"Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice","volume":"87","author":"Turner","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtn.2023.102086_bib57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.20191","article-title":"Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS","volume":"77","author":"Rembach","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.omtn.2023.102086_bib58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"Hu","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.102086_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41418-021-00914-9","article-title":"The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities","volume":"29","author":"Iennaco","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omtn.2023.102086_bib60","first-page":"55","article-title":"Peptide nucleic acid-based targeting of microRNAs: possible therapeutic applications for glioblastoma","volume":"2019","author":"Gambari","year":"2019","journal-title":"J.\u00a0Cancer Metastasis Treat."},{"key":"10.1016\/j.omtn.2023.102086_bib61","doi-asserted-by":"crossref","first-page":"eabq7459","DOI":"10.1126\/sciadv.abq7459","article-title":"Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2023.102086_bib62","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41575-022-00736-1","article-title":"Therapeutic landscape and future direction of metastatic colorectal cancer","volume":"20","author":"Bando","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2023.102086_bib63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/cancers15010128","article-title":"MicroRNAs miR-584-5p and miR-425-3p Are Up-Regulated in Plasma of Colorectal Cancer (CRC) Patients: Targeting with Inhibitor Peptide Nucleic Acids Is Associated with Induction of Apoptosis in Colon Cancer Cell Lines","volume":"15","author":"Gasparello","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2023.102086_bib64","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1158\/0008-5472.CAN-21-0736","article-title":"Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy","volume":"81","author":"Dhuri","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2023.102086_bib65","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-022-03383-y","article-title":"Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines","volume":"39","author":"Dhuri","year":"2022","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.omtn.2023.102086_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/EBC20150001","article-title":"Introduction to biosensors","volume":"60","author":"Bhalla","year":"2016","journal-title":"Essays Biochem."},{"key":"10.1016\/j.omtn.2023.102086_bib67","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/molecules22111951","article-title":"Peptide Nucleic Acid-Based Biosensors for Cancer Diagnosis","volume":"22","author":"D'Agata","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2023.102086_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/cr0684467","article-title":"DNA Biosensors and Microarrays","volume":"108","author":"Sassolas","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.omtn.2023.102086_bib69","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/molecules25061296","article-title":"PNA-Based MicroRNA Detection Methodologies","volume":"25","author":"Cadoni","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2023.102086_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bios.2017.11.024","article-title":"Pyrrolidinyl PNA polypyrrole\/silver nanofoam electrode as a novel label-free electrochemical miRNA-21 biosensor","volume":"102","author":"Kangkamano","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.omtn.2023.102086_bib71","doi-asserted-by":"crossref","first-page":"12451","DOI":"10.1039\/C9CC05607F","article-title":"Oligonucleotide-templated lateral flow assays for amplification-free sensing of circulating microRNAs","volume":"55","author":"Pavagada","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.omtn.2023.102086_bib72","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/mi11070628","article-title":"Analysis of Single Nucleotide-Mutated Single-Cancer Cells Using the Combined Technologies of Single-Cell Microarray Chips and Peptide Nucleic Acid-DNA Probes","volume":"11","author":"Shigeto","year":"2020","journal-title":"Micromachines"},{"key":"10.1016\/j.omtn.2023.102086_bib73","doi-asserted-by":"crossref","first-page":"e2100587","DOI":"10.1002\/biot.202100587","article-title":"A highly sensitive PNA-microarray system for miRNA122 recognition","volume":"17","author":"Forte","year":"2022","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2023.102086_bib74","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1039\/C5AN00128E","article-title":"A peptide nucleic acid-functionalized carbon nitride nanosheet as a probe for in\u00a0situ monitoring of intracellular microRNA","volume":"140","author":"Liao","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.omtn.2023.102086_bib75","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2180-13-82","article-title":"Fluorescence in\u00a0situ Hybridization method using Peptide Nucleic Acid probes for rapid detection of Lactobacillus and Gardnerella spp","volume":"13","author":"Machado","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.omtn.2023.102086_bib76","doi-asserted-by":"crossref","first-page":"e0201332","DOI":"10.1371\/journal.pone.0201332","article-title":"Accelerated bacterial detection in blood culture by enhanced acoustic flow cytometry (AFC) following peptide nucleic acid fluorescence in\u00a0situ hybridization (PNA-FISH)","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2023.102086_bib77","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3390\/microorganisms10071409","article-title":"Development of a Novel Peptide Nucleic Acid Probe for the Detection of Legionella spp. in Water Samples","volume":"10","author":"N\u00e1cher-V\u00e1zquez","year":"2022","journal-title":"Microorganisms"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123003049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123003049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:41:40Z","timestamp":1760856100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123003049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2162253123003049"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.102086","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic and diagnostic applications of antisense peptide nucleic acids","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.102086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"102086"}}